Pharmacological Basis of Differences in Dose Response, Dose Equivalence, and Duration of Action of Inhaled Corticosteroids

CONCLUSION: In a real-world clinical setting where there may be poor adherence to prescribed therapy, our findings suggest a significant therapeutic advantage for longer-acting ICS molecules in patients with asthma.PMID:38532238 | DOI:10.1007/s12325-024-02823-y

Source: Adv Data - March 27, 2024 Category: Epidemiology Authors: Peter T Daley-Yates Bhumika Aggarwal Maximilian Plank Source Type: research